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a b s t r a c t
The ﬁtness landscape is a powerful metaphor for describing the relationship between genotype and phenotype
for a population under selection. However, empirical data as to the topography of ﬁtness landscapes are limited,
owing to difﬁculties in measuring ﬁtness for large numbers of genotypes under any condition. We previously
reported a case of reciprocal sign epistasis (RSE), where two mutations individually increased yeast ﬁtness in a
glucose-limited environment, but reduced ﬁtness when combined, suggesting the existence of two peaks on
the ﬁtness landscape. We sought to determine whether a ridge connected these peaks so that populations
founded by one mutant could reach the peak created by the other, avoiding the low-ﬁtness “Valley-of-Death”
between them. Sequencing clones after 250 generations of further evolution provided no evidence for such a
ridge, but did reveal many presumptive beneﬁcial mutations, adding to a growing body of evidence that clonal
interference pervades evolving microbial populations.
© 2014 Elsevier Inc. All rights reserved.

1. Introduction
Natural Historians are fond of citing the many ways in which organisms are well-suited to their environments, so much so that the adaptationist paradigm holds a seductive power over the scientiﬁc imagination
[1]. In its most extreme form, that paradigm leads to the conclusion that
an organism can be atomized into a set of traits, each of which is optimally adapted to serve a particular function. But every trait, be it the
ratio of a beak's length to its depth or a protein's kcat/Km, arises from interactions among its component elements, subject to past phylogenetic
and current biophysical constraints. Moreover, every trait itself interacts
with myriad elements to generate other traits. Thus, the study of the
adaptive process is fundamentally the study of how these nested interactions respond over time to mutation and selection. Proving that a trait
is “adaptive” is non-trivial, as it requires showing not only that the trait
confers a ﬁtness beneﬁt but that it also has a heritable basis [2]. Demonstrating how an adaptive trait arose can prove even more daunting
because detailed knowledge is also required of the phylogenetic history
of the population in which the trait arose. For those many species that
have a long generation time and a sparse fossil record, the adaptive process can only be studied retrospectively using comparative methods. By
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contrast, because many microbes have short generation times and can
be cryopreserved, the adaptive process can be studied in these species
prospectively using experimental methods. Empowered by advances
in high-throughput sequencing and phenotyping, experimental microbial evolution now offers the possibility of mapping the adaptive
process as it unfolds at the genomic scale in real time.
A powerful metaphor for envisioning the adaptive process is the ﬁtness landscape, ﬁrst introduced by Sewall Wright in the 1930s [3]. This
concept enables us to represent in multiple dimensions the relationship
between genotype and ﬁtness for a population under selection, and
thereby identify the various mutational paths by which lineages can
evolve from genotypes that lie in valleys of low ﬁtness to genotypes
that occupy peaks of high ﬁtness [4]. The ﬁtness landscape has ﬁnescale topography: when it is smooth, all adaptive mutational paths
will eventually converge on one genotype, the global optimum, whose
ﬁtness is greatest for the selection regime under consideration. When
the topography is rugged, there exist multiple peaks and adaptation is
constrained, as the mutations available to increase the population's ﬁtness depend on the founder's genotype [5]. Different genotypes may
evolve to reach different peaks in such a landscape (and indeed, a single
genotype may not always reach the same peak when evolved under the
same condition). For example, Escherichia coli's TEM-1 can be co-opted
to confer a novel phenotype, cefotaxime resistance; however, biophysical pleiotropy in this protein limits the number of mutational trajectories leading to the novel phenotype [6]. In vitro selection experiments
have shown that cefotaxime resistance evolves with a high degree of
parallelism: three mutations usually occur in ﬁxed order [7]. Rarely,
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different initial substitutions create alternative paths that lead to cefotaxime resistance, albeit at lower levels than that achieved via the
most common trajectory. All else being equal, the rate of adaptive
evolution in a “rugged” landscape having multiple adaptive peaks is
slower than in a smooth landscape having one global optimum:
“rugged” landscapes are more functionally constrained [8], and some
fraction of the population can become trapped on peaks of different
heights.
Although a plethora of theoretical and empirical studies have explored the causes and consequences of different ﬁtness landscapes, it
is still an outstanding question as to whether most are simple, essentially being Mount Fuji-like [9], containing a single global ﬁtness optimum,
or whether they are complex, with selective constraints on differing
mutational trajectories creating multiple local ﬁtness optima [5,
10–13]. In part, this uncertainty arises from the perspective of what is
the trait under consideration and what aspect of that trait is being
optimized by selection in the framework of a ﬁtness landscape? Is it a
protein's activity [14] or its cofactor binding afﬁnity [15]? Is it the regulatory response of a repressor–operator pair [16] or is it the rate of a process such as CO2 assimilation [9]? And if it actually is true Darwinian
ﬁtness, is ﬁtness estimated in terms of differential reproduction [17]
or in terms of differential survivorship [7], or as is possible in microbial
studies, both?
Regardless of one's perspective, genetic constraints on the adaptive
landscape stem from a common source, epistasis, where a mutation's
effect on ﬁtness depends on the genetic background in which it arises
[12]. Theory has shown that sign epistasis, wherein a mutation is beneﬁcial within the context of some genetic backgrounds, but detrimental
within others, can constrain mutational trajectories on ﬁtness landscapes [18]. In particular, the creation of rugged ﬁtness landscapes
with their local peaks and valleys depends critically on “reciprocal
sign epistasis” (RSE), wherein the mutational path between two genotypes becomes inaccessible to selection due to an intermediate lowﬁtness genotype [13,18,19]. Such valleys of low ﬁtness are less likely
to be “crossed” by the action of natural selection, mutation and drift
[20]. Under RSE, genotypes that reside at local ﬁtness optima may become evolutionary dead-ends. Even if a higher ﬁtness peak exists elsewhere on the landscape, “Valleys-of-Death” adjacent to these local
optima create barriers to adaptive evolutionary change.
A variety of experimental approaches have been used to discover
how mutational constraints shape ﬁtness landscapes, each with its
own measure of ‘ﬁtness.’ At the level of single proteins, differences in
catalytic activity have been assayed by substituting different residues
at an enzyme active site(s) [14,21,22], and by constructing evolutionary
intermediates between the ancestral and evolved states [6,23,24].
When the phenotypic consequences of mutations in different genes
have been studied sign epistasis appears to be prevalent ([17,25–28]
but see [25]), which may explain why adaptation takes surprisingly
few mutational paths to optimal genotypes. Some genotype–phenotype
mapping studies using molecular data have inferred a multi-peaked
landscape using proxies for ﬁtness, but the extent of the role played
by local optima during adaptation was either unknown [28] or limited
[21,29].
For clonal populations evolving in a constant environment, theory
suggests that RSE is required to establish a rugged adaptive landscape
[19]. But how often do empirical ﬁtness landscapes exhibit such topography? Analysis of in vivo data on repressor–operator pairs in the lac
system of E. coli reveals 19 distinct peaks [16]. Multiple, deep ﬁtness valleys have recently been demonstrated in adaptation of HIV-1 to its secondary cell-surface chemokine co-receptor, CXCR4 [30,31]. In the plant
RNA virus TEV, RSE was the most common type of epistasis, accounting
for 55% of signiﬁcant gene interactions [32]. In addition, a considerable
body of clinical data points to the existence of inaccessible evolutionary
trajectories in diseases such as colorectal cancer [33,34], blastic
plasmacytoid dendritic cell neoplasm [35], secondary glioblastomas
[36] and lung adenocarcinoma [37]. That so many alleles linked to

cancers are mutually exclusive suggests that reciprocal sign epistasis
may be a pervasive feature of their adaptive landscapes.
A clonal population may traverse an adaptive “Valley-of-Death”
stemming from RSE when environmental change alters the topography
of its ﬁtness landscape [38], as well as when recombination (e.g., [39])
and/or gene ﬂow creates a genetic overpass. Alternatively, a neutral or
adaptive ridge might provide an alternative path connecting one peak
to another. The likelihood that such a route can be successfully followed
depends on mutational path length and the ease with which the
population can explore that ridge, subject to its size and mutation
rate. For example, in the TEM β-lactamase system, although the landscape leading to cefotaxime resistance appears locally rugged, recent
analyses indicate the existence of multiple adaptive pathways that
lead to a global optimum of maximal resistance [40]. Clearly, predictive
treatment of infectious disease and cancer will beneﬁt from maps of empirically determined ﬁtness landscapes that describe not only the height
of local and global optima, but also the topography of adaptive ridges
that may provide routes for therapeutic escape.
We have previously described a rugged ﬁtness landscape that we
discovered during the experimental evolution of yeast in a constant,
glucose-limited environment [41]. We identiﬁed two mutually exclusive mutations, a nonsense mutation in mth1-1 and an ampliﬁcation
involving the HXT7/6 locus. Each mutation arose multiple times in independent lineages; individually each mutation was strongly adaptive
(with the HXT7/6 ampliﬁcation resulting in higher ﬁtness than the
mth1-1 mutant), but in combination, within the same individual, the
resulting strain was not only less ﬁt than the two single mutants, but
also less ﬁt than their wild-type ancestor, a clear case of reciprocal
sign epistasis. HXT7 and HXT6 are almost identical, tandemly-arrayed
genes encoding high-afﬁnity hexose transporters that have been repeatedly observed to undergo fusion and ampliﬁcation in yeast evolving
under glucose limitation [42,43]. MTH1 encodes a negative regulator of
the glucose-sensing pathway, and its inactivation has been shown to elevate HXT expression [44]. Here, we set out to determine whether there
exists either a neutral or an adaptive ridge between the two ﬁtness
peaks deﬁned by these mutually exclusive mutations. We founded
replicate experimental evolution experiments wherein one of the mutations, mth1-1, was ﬁxed in the population, and then sought to determine
whether the other mutation arose. Using PCR, we screened for hxt7/6
ampliﬁcations in populations that had evolved for ~ 250 generations
under conditions identical to those described in [41]. In addition, we
also performed whole genome resequencing on multiple clones drawn
from each of three replicate experiments. We did not uncover any evidence for the occurrence of the other mutation, suggesting the possible
existence of an adaptive ‘Valley-of-Death’ in which hxt7/6 ampliﬁcations
cannot rise to appreciable frequency. However, we did discover a myriad
of other mutations distributed among the clones we sequenced, many
of which are plausibly beneﬁcial. The discovery of multiple adaptive
lineages coexisting in the same population adds to a growing body of
evidence that clonal interference is a pervasive feature of microbial
evolution, and that at any given time there may exist a plethora of highly
ﬁt lineages, each of which prevents the others from going to ﬁxation.
2. Results
2.1. Evolution of the mth1-1 mutant under glucose limitation provides
evidence for clonal interference
The mth1-1 allele, originally isolated and described in [44], contains
a C to T transition that results in a Gln to Stop nonsense mutation at
amino acid 338 of Mth1, removing the terminal 96 amino acids. We
introduced mth1-1 into three otherwise isogenic Mat-α strains that
carried one of three different ﬂuorescent markers: GFP, DsRed, YFP
(see Materials and methods section). Our previous work [44] had demonstrated that the growth rates of these marked strains did not signiﬁcantly differ from one another. Overnight cultures of ﬂuorescently
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tagged mth1-1 strains were pooled at approximately equal frequencies,
and used to inoculate three independent bioreactors, each of which
contained 300 mL 0.08% glucose Delft minimal media [45]. Following
overnight incubation in batch, cultures were switched to continuous
mode and grown for ~ 25 generations at D ≈ 0.1 h− 1 then for 225
generations at D ≈ 0.17 h−1 under continuous glucose limitation. In
no case did we observe a single ﬂuorescently-tagged lineage go to
ﬁxation following 250 generations of evolution (Fig. 1), suggesting
that clonal interference maintained a complex population genetic
structure in evolving populations originating from an mth1-1 ancestor,
as we had seen previously in experiments founded by a wild-type
clone [44].

2.2. A PCR screen reveals no increase in HXT copy number among
independent populations founded by mth1-1 nonsense mutants
To determine whether the HXT6/7 ampliﬁcation arose in any of the
three independent populations founded by haploid yeast carrying the
mth1-1 allele, we performed PCR on genomic DNA from population
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samples, using primers that speciﬁcally detect the tandem duplication
of the locus. We determined that we can detect the ampliﬁcation
when it is present in a frequency of ≥0.10 from reconstruction experiments. Thus, in mixing experiments, containing genomic DNA from a
wild-type strain mixed with genomic DNA from a mutant strain carrying the tandem duplication, we were consistently able to PCR amplify
a band when the DNA of the mutant strain was in a frequency of 0.10
or greater of the DNA mix, but not when the DNA was present at a frequency of ≤0.01 (data not shown). To determine whether the ampliﬁcation had arisen in any of the three evolved populations, we performed
PCR as described above on DNA extracted from generation ~ 250 on
samples for each of the three evolved populations. In no case did we observe the diagnostic band that is produced by the tandem duplication of
the HXT6/7 locus, observed in positive controls (data not shown). To
further determine whether the ampliﬁcation might be present at low
frequency, we performed the diagnostic PCR on 48 individual clones
randomly selected from the ~ 250 generation population for each of
the 3 evolved populations. Again, in no instance did we observe ampliﬁcation of the diagnostic band, which was present in positive controls,
suggesting that if the ampliﬁcation is present with the 250 generation
population, then it is present in ~2% or less of the population. We therefore conclude that, while ampliﬁcations of the locus may occur, they do
not rise to high frequency in our experimental evolutions, likely due to
the reciprocal sign epistasis between them and the pre-existing mth1-1
allele.
2.3. Clonal sequencing also provides additional evidence that HXT6/7 ampliﬁcation mutations do not reach high frequency in an mth1-1 background
evolving under glucose limitation
To investigate further whether the HXT6/7 ampliﬁcation occurs in an
mth1-1 background, and to also determine if other mutations arose
during this evolution, we selected a total of 17 clones from the terminal
experimental evolution populations (four in population 1, six in population 2, seven in population 3) and performed whole genome resequencing. Signiﬁcantly, all of these clones retained the mth1-1 allele;
consistent with our PCR results, while none showed (hxt6/7)n ampliﬁcation. Thus, while the hxt6/7 ampliﬁcation can be crossed into an mth1-1
background, resulting in a strain with ﬁtness lower than wild-type [41],
we uncovered no evolutionary trajectory that allowed this combination
of alleles to arise.
2.4. Clone sequencing uncovers other mutations arising in an mth1-1
background, some of which may have adaptive value under glucose
limitation

Fig. 1. Dynamics of ﬂuorescent tags indicate pervasive clonal interference: (A) population
1, (B) population 2, (C) population 3.

A total of 81 Single Nucleotide Polymorphisms (SNPs) and indels
were discovered among the seventeen sequenced mth1-1 clones
relative to the founder (Tables 1–3). 43 of these resulted in nonsynonymous changes to coding sequences, while 4 resulted in synonymous changes; 6 introduced premature STOP codons, and 2 resulted
in frameshifts. 1 SNP was in an intron, 8 SNPs occurred upstream of
coding sequences, 8 occurred immediately downstream and 8 were
classiﬁed as intergenic. All of the evolved clones retained the ancestral
mth1-1 nonsense mutation. Only one other SNP was observed in three
populations: fourteen of seventeen clones shared a T → A transversion
at position 371865 on Chr. II. This SNP occurs downstream of TIP1,
which encodes a major cell wall mannoprotein. Other than mth1 and
tip1 mutations, ﬁfteen SNPs were observed in more than one clone; as
expected for independently evolving populations, all ﬁfteen were
shared only among a subset of clones isolated from any one population
(Tables 1–3).
A number of these mutations occurred in genes in which mutations
have been observed in other yeast evolution experiments carried out
under continuous glucose limitation. For example, three of six clones sequenced in population 2, carry a nonsense mutation in GIN4 (G → C,
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Table 1
Summary of SNPs detected in sequenced clones from population 1, where yellow indicates the presence of the SNP.
#CHROM
chrII
chrII
chrIV
chrVI
chrVII
chrVII
chrVIII
chrX
chrXII
chrXIII
chrXV
chrVIII
chrVIII
chrXII
chrXIV
chrII
chrXI

POS
371865
275399
727219
102407
348047
994190
81842
172326
221252
891857
593444
58100
85558
893967
674942
237120
609417

GENE(S)
TIP1
GAL7
YCF1
LPD1
MAD1
ETP1, PRS3
URA2
YLR036C
PSE1
LSC1
RIM4
LTR
VAC14
BUD17
ECM15, HTB2
PXL1

Effect
DOWNSTREAM
STOP_GAINED
NON_SYNONYMOUS
NON_SYNONYMOUS
NON_SYNONYMOUS
INTERGENIC
INTERGENIC
NON_SYNONYMOUS
DOWNSTREAM
NON_SYNONYMOUS
STOP_GAINED
NON_SYNONYMOUS

Codon

AA

taC/taA
atG/atT
Gca/Cca
gAt/gTt

Y/*
M/I
A/P
D/V

NON_SYNONYMOUS
NON_SYNONYMOUS
DOWNSTREAM
NON_SYNONYMOUS

atG/atT

M/I

cTa/cCa
Caa/Taa
atG/atT

L/P
Q/*
M/I

Gca/Tca
aCg/aAg

A/S
T/K

Cat/Aat

H/N

S1035*) that encodes a protein kinase involved in bud growth and assembly. A GIN4 missense mutation was reported by Gresham and
colleagues [43] to attain N 20% frequency in populations founded by
haploid S288C after 200 generations of evolution under glucoselimitation. As these same three clones in population 2 also share a missense mutation in PBS2 (G → C, A56G) and an intergenic mitochondrial
T → A transversion, they are likely members of the same lineage. Notably, mutations in PBS2 have also been observed to arise multiple times
in populations evolving under glucose limitations, in each case those
mutations predicted to be disruptive [46]. Four of seven clones sequenced in population 3 carry a missense mutation (T2502K) in IRA2,
a GTPase-activating protein that negatively regulates RAS. Because
these four ira2 mutants share SNPs not only at MTH1, but also at SSA4,
CRG1, and COX3, they are almost certainly members of the same lineage
(though they can be distinguished from one another by additional
unique SNPs). A ﬁfth clone in population 3 bears a nonsense mutation
at a different position in IRA2 (E2736*). Presumptive loss of function
mutations in IRA2, as well as in its paralog IRA1, have previously been
observed in adaptive clones evolving under conditions where glucose
is either periodically [47,48] or continuously limiting [44,46,49]. Indeed,
loss of nutrient signaling via any one of several possible mechanisms
appears to be selected for in populations evolving in continuous culture
under glucose limitation. Signiﬁcantly, we have shown previously that
IRA1/2 and MTH1 mutations can arise in the same background, and
attain high frequency [46]. It is noteworthy that allelic variation at
IRA1 and IRA2, which are homologs of the hypermutable human neuroﬁbromatosis gene NF1, results in diverse morphological and growth
phenotypes in Saccharomyces paradoxus [50].

REF
T
G
C
C
A
C
G
C
G
A
C
G
G
G
C
G
C

ALT
A
T
A
G
T
T
T
A
T
G
T
T
A
T
A
T
A

GSY2737

GSY2736

GSY2734

GSY2735

Other mutational targets in our experiments have previously been
reported as being selected under constant or periodic glucose limitation.
These include ACE2 (Y594S), a transcription factor required for septum
destruction after cytokinesis, observed in two clones from population 2
and also by [46]. Interestingly, mutations in ACE2 have recently been
shown to underlie rapid evolution of multicellular, fast-sedimenting phenotypes in yeast [51]. We also observed mutations in the sphingolipid
biosynthetic gene LCB1 (D320E) in two different clones from population
2; mutants in the same pathway (LCB3) were previously observed by
[46] in evolving populations under glucose limitation. As these pairs
of clones share, respectively, mutations in PBS2 (G → C, A56G) and in
PET10 (G → T, S65R), we conclude that repeated observation of ACE2
and LCB1 alleles in population 2 is not due to their having arisen independently but rather to their being shared by descent. We also observed
a nonsense mutation in MUK1 (C → A, Y275*), which truncates the predicted Muk1 protein at less than half its length, removing a candidate
VPS9 domain. We have previously observed MUK1 mutations in other
populations evolving under glucose limitation [44,49]. Recently, MUK1
has been shown to encode a guanosine nucleotide exchange factor
(GEF) for proteins involved in Golgi trafﬁcking and endocytosis [52,
53]. A link between these functions and increased ﬁtness in populations
evolving under glucose-limitation is unclear; indeed, we previously
showed [41] that alone, MUK1 has no ﬁtness effect, suggesting that
either it requires another mutation in the background in an epistatic
fashion, or possibly that MUK1 simply has a higher mutation rate than
many genes.
Finally, in addition to observing two IRA2 mutations, we also
observed independent mutations in MIT1, in populations one and

Table 2
Summary of SNPs detected in sequenced clones from population 2, where yellow indicates the presence of the SNP. Gene names in red, bold fonts are genes which were either mutated
recurrently in our experiments, or in which mutations have been observed previously in other glucose limited chemostat evolutions.
#CHROM POS
chrII
371865
chrIV
329069
chrV
143645
chrV
143646^143647
chrXI
524880
chrXIII
859932
chrXV
988368
chrII
600545
chrVI
108690
chrXIII
420692
chrXI
313785
chrXII
770185
chrXIV
368081
chrIV
1462683
chrX
179937
chrMito
57268
chrXII
405042
chrII
85054
chrX
237313
chrX
364859
chrXIV
144125
chrXVI
926957
chrVII
44172
chrXV
902077
chrV
476850
chrVIII
197604
chrXII
953417
chrXIV
736085

GENE(S)
TIP1
YDL073W
MIT1
MIT1
PET10
LCB1
PUT4
PCH2
IES1
tV(AAC)M2
tH(GUG)K
BUD6
SRV2
GIN4
PBS2
ACE2
SSA3
LSB6
MHP1
IST1, PIK1
OPT2
TAD1
SPS4
BEM2
INM1
PUN1
BIO3

Effect
DOWNSTREAM
SYNONYMOUS
NON_SYNONYMOUS
FRAMESHIFT
NON_SYNONYMOUS
NON_SYNONYMOUS
NON_SYNONYMOUS
UPSTREAM
NON_SYNONYMOUS
UPSTREAM
UPSTREAM
NON_SYNONYMOUS
NON_SYNONYMOUS
STOP_GAINED
NON_SYNONYMOUS
INTERGENIC
NON_SYNONYMOUS
SYNONYMOUS
NON_SYNONYMOUS
NON_SYNONYMOUS
DOWNSTREAM
UPSTREAM
NON_SYNONYMOUS
NON_SYNONYMOUS
NON_SYNONYMOUS
NON_SYNONYMOUS
NON_SYNONYMOUS
DOWNSTREAM

Codon

AA

ctG/ctC
YEL007W:c.1754T>G, YEL007W:p.Met585Arg
YEL007W:c.1755_1756insG, YEL007W:p.Tyr586fs
agC/agA
gaC/gaA
Tgc/Cgc

L/A
S/R
D/E
C/R

gAg/gGg

E/G

aaC/aaA
ttT/ttA
tCa/tGa
gCt/gGt

N/K
F/L
S/*
A/G

tAc/tCc
gcT/gcG
aaG/aaC
gCa/gTa

Y/S
A/A
K/N
A/V

cCa/cGa
atT/atG
gGa/gCa
Tat/Cat
aGc/aAc

P/R
I/M
G/A
Y/H
S/N

REF
T
G
T
G
G
A
A
T
A
C
G
T
G
G
T
T
A
G
C
C
G
C
A
C
A
C
C

ALT
A
C
G
G
T
T
G
G
C
G
T
T
A
C
C
A
G
C
C
T
G
T
G
C
G
G
T
T

GSY4318 GSY4322 GSY4319 GSY4323

GSY4321

GSY4324
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Table 3
Summary of SNPs detected in sequenced clones from population 3, where yellow indicates the presence of the SNP. Gene names in red, bold fonts are genes which were either mutated
recurrently in our experiments, or in which mutations have been observed previously in other glucose limited chemostat evolutions.
#CHROM POS
GENE(S)
Effect
chrII
371865 TIP1
DOWNSTREAM
chrI
128481 SYN8
FRAMESHIFT
chrV
364256 SSA4
UPSTREAM
chrVIII
519892 CRG1
SYNONYMOUS
chrXV
178574 IRA2
NON_SYNONYMOUS
chrMito
80513 COX3
DOWNSTREAM
chrIV
1289911 SIZ1
NON_SYNONYMOUS
chrX
666710 STR2
NON_SYNONYMOUS
chrXII
147914 DNM1
NON_SYNONYMOUS
chrXV
606620 MDM32
NON_SYNONYMOUS
chrIV
67810 TIM22, YDL218W DOWNSTREAM
chrIV
183707 RPC53
NON_SYNONYMOUS_CODING
chrVIII
167568 YHR028W-A
NON_SYNONYMOUS
chrX
304208 JEM1
NON_SYNONYMOUS
chrXI
158736 RPS27A
INTRON
chrXI
647912 FLO10
SYNONYMOUS
chrXVI
416459 YTA6
NON_SYNONYMOUS
chrII
452501 PHO88
UPSTREAM
chrXV
557840 UBP2
NON_SYNONYMOUS
chrIII
283793 CDC39
NON_SYNONYMOUS
chrVII
321148
INTERGENIC
chrVIII
524447
INTERGENIC
chrIV
675571 YDR109C
NON_SYNONYMOUS
chrIV
785856 TRM82
NON_SYNONYMOUS
chrVIII
418602 TDA11
STOP_GAINED
chrIX
89756 TMA108, TPM2
INTERGENIC
chrXII
838026 ILV5
DOWNSTREAM
chrXV
179275 IRA2
STOP_GAINED
chrXVI
95218 CIN2, IQG1
INTERGENIC
chrXVI
421772 MUK1
STOP_GAINED
chrV
143507 MIT1
NON_SYNONYMOUS
chrXII
921722 BDF1, YLR400W UPSTREAM
chrXV
213387 PRS5
NON_SYNONYMOUS
chrIX
69868 SLN1
NON_SYNONYMOUS
chrXIV
119311 BOR1
NON_SYNONYMOUS
chrXVI
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three. Little is know about MIT1, though it appears to be a transcriptional
regulator of bioﬁlm development [54].
3. Discussion
3.1. The spectrum of mutations arising in an mth1-1 background is
conspicuously lacking in other variants that would degrade nutrient
signaling pathways
Ampliﬁcation of hxt6/7 chimeras has been repeatedly observed to
occur in yeast as an adaptive response to glucose limitation, but this
path to increased ﬁtness appears to be closed to mth1-1 strains. Other
mutations that might be expected to increase the capacity of cells to
scavenge limiting glucose include those that alter nutrient signaling
via the cAMP/PKA [43,46,49] and HOG pathways [46]. As noted, ﬁve of
seven sequenced clones in population 3 had IRA2 mutations that are
likely to increase Ras activity, and thus cAMP/PKA signaling, while
three of six clones in population 2 had mutations in PBS2, and one of
seven clones in population 3 has a mutation in SLN1, both of which
are predicted to affect signaling via the HOG pathway, as has been observed in [46,49]. However, a number of other targets, whose impact
on nutrient signaling is known to confer a ﬁtness advantage under glucose limitation, were not mutated; these targets include: RIM15 and
RGT2 [43,46], and CYR1 [49]. Failure to recover mutants at these loci
may be due to their diminishing returns on ﬁtness in an mth1-1 background, to the limited number of clones we sampled, the relatively
short duration of the experiment, or possibly, to negative sign epistasis
preventing (htx6/7)n mutants from attaining appreciable frequency.
Clearly, population sequencing or similar approaches, with the ability
to identify mutations that reach a 0.01 allele frequency or more, are
needed to gain deep insight into how the beneﬁcial mutational spectra
might differ between replicate populations evolving under the same
conditions, but with different founding genotypes.
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to potential competitors, or a genotype may simply become more proﬁcient at using the limiting substrate so that it produces more progeny
per unit resource than potential competitors. In yeast, one or both strategies may come into play, depending on evolutionary trajectory and on
the availability of oxygen as the terminal electron acceptor for respiratory metabolism. Ferea et al. [56] demonstrated that evolution of an
S288C-derivative under glucose limitation resulted in genotypes that
exhibited, relative to their common ancestor, superior glucose uptake
kinetics and lower residual substrate concentrations. Under aerobic
conditions, evolved diploids showed greater than 3-fold yield than
their common ancestor. When cultured under anaerobic conditions,
these yield differences largely disappeared, yet evolved strains were
nevertheless more ﬁt than their common ancestor, owing to their superior glucose uptake capacities [49]. We know that the mth1-1 allele confers a ﬁtness advantage over wild type in pairwise competition [41], but
we do not know if this genotype occupies a ﬁtness peak that restricts
further improvements in performance. To test this we measured residual glucose (s), cell number, and dry weight biomass in populations
founded by mth1-1 mutants before and after 250 generations of evolution. We found that while the scope for improvement in physiological
performance did not approach that observed in previously reported
populations evolving under glucose-limitation, cells did become
signiﬁcantly more proﬁcient in their uptake of the limiting substrate
(s = 0.043 ±0.013 mg mL−1 vs. 0.028 ± 0.044 mg mL−1, t-test, P =
0.0321) and in their yield of cells per mg glucose consumed (4.33 ±
0.29 × 107 vs. 5.72 ± 0.31 × 107, t-test, P = 0.0313). We therefore
conclude that under glucose limitation the scope for selection for
(hxt6/hxt7)n and other beneﬁcial mutations appears to be diminished
in an mth1-1 background. While this genotype may not occupy the
summit of a ﬁtness peak, it very likely resides at a higher elevation
than wild type strains used to initiate previous populations evolving
under glucose-limitation.
3.3. The nature of reciprocal sign epistasis

3.2. Does introgression of mth1-1 elevate wild-type yeast onto a ﬁtness
peak?
Theory suggests that there are generally two mechanisms by which
higher ﬁtness can be achieved in a continuous, resource-limited environment [55]. A genotype may become so efﬁcient at scavenging the
limiting substrate that the substrate effectively becomes inaccessible

The predicted product of the wild-type MTH1 gene is a 433 amino
acid protein that interacts with Snf3 and Rgt1 and Rgt2, and serves as
a negative regulator of the glucose-sensing pathway. Mth1 inhibits protein kinase A-dependent phosphorylation of Rgt1 [57], while inactivation of Mth1 and its paralog Std1 leads to hyperphosphorylation of
Rgt1 and its dissociation from hexose transporter promoters (HXT) in
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the absence of glucose [58], bypassing the requirement of Grr1 for
HXT induction. We showed previously that this nonsense mutation in
MTH1 increases HXT expression, especially of HXT1 and HXT4 (see
Supp. Fig. 1 in [44]), providing a clear ﬁtness advantage to yeast evolving in constant low glucose conditions. Further analysis of yeast populations that evolved under glucose limitation (see [44]) revealed
additional, independently derived mth1 alleles that also contain nonsense mutations [41]. Because both mth1-1 and HXT6/7 ampliﬁcation
mutations are predicted to increase the abundance of hexose transporters in the plasma membrane, their apparent mutual exclusivity suggests that there may be either an upper limit to, or and optimal number
of these proteins under the glucose limiting conditions. In the case of the
double mutant, this limit or optimum is overshot, leading to decreased
ﬁtness. Whether this is a generalizable principle for mutually exclusive
mutations (that is, when a pathway has an optimum under one condition, that optimum may shift under another condition) will require
signiﬁcantly more investigation. However, in the particular case of
hexose transporter expression, it may be relatively straightforward to
derive a function mapping ﬁtness to hexose transporter transcription
under various experimental conditions then to determine if the
resulting surface has a simple maximum.
3.4. Alternative approaches to ﬁnd a neutral or beneﬁcial ridge
In this investigation, we attempted to determine if ampliﬁcation of
the HXT6/7 locus could occur during experimental evolution on an
mth1-1 background. While we did not observe this outcome, there are
many reasons that we may not have observed it, chief among them
that an insufﬁcient number of generations had elapsed by the termination of the populations. Alternatively, it is possible that we could have
observed the HXT6/7 ampliﬁcation on the mth1-1 background, but that
the other mutations required to make that observation might have
placed the evolved individuals on yet a new peak, rather than at a
new point on our imagined HXT6/7 peak. Distinguishing between such
possibilities would be challenging, in the absence of a mapping of the
ﬁtness landscape at high resolution across many related genotypes. An
alternative approach might be to start evolution experiments with the
double mth1-1 (hxt6/7)n mutant, and to select for compensatory mutations, which relieve the reciprocal sign epistasis. If clones were isolated
with compensatory mutations that are neutral in the wild-type background, it would suggest that they might provide such a neutral ridge
as we originally postulated.
4. Materials and methods
4.1. Strains
The ancestral strains used in these experiments are derived from
GSY1171 (strain M1 in Kao and Sherlock 2008) [44]. The ancestral population consisted of equal numbers of GSY3087, GSY2674, and GSY2672,
which were constructed so as to contain the mth1-1 allele (Gln338*)
previously described by [44] and [41] as well as a chromosomally integrated gene encoding GFP, YFP or DsRed. Founder strains were created
by crossing GSY1171 (Mat-α ura3-52 GAL2+ YBR209W::Act1p-GFPAct1t-URA3 mth1 in an S288c background) to one of three FP-marked
Mat-a strains derived from FY2 [59]: GSY1221 (ura3-52 GFP),
GSY1222 (ura3-52 YFP) and GSY1223 (ura3-52 DsRed). The diploids
produced by these matings were sporulated, and Mat-alpha haploids
were isolated to create the ancestral population.
4.2. Media and culture conditions
Yeast strains were routinely maintained on either liquid or solid YEP
medium containing 1% (w/v) dextrose. The ancestral population was
created by culturing single colony isolates of GSY3087, GSY2674, and
GSY2672 overnight in YEPD at 30 °C, then apportioning equal numbers

of the differently labeled mth1-1 strains into each of three 300 mL working volume bioreactors (ATR SixFors fermentation apparatus, ATR
Biotechnologies). Following overnight batch culture, reactors were initially run in continuous mode at a dilution rate, D, of 0.1 h−1 for ~ 25
generations, then for an additional 225 generations at D = 0.17 h−1.
Evolution experiments were carried out at 30 °C using the Delft minimal medium described by [45] amended with 0.08% (w/v) glucose. Aerobic conditions were maintained by sparging cultures with sterile
humidiﬁed air (25 L h−1). Glucose-limited chemostats were sampled
every day to determine absorbance at 660 nm, to create an archive of
−80 °C glycerol stocks (20% v/v), and to estimate the number of colony
forming units (CFU) per mL on YEPD agar. At 50-generation intervals
cells were withdrawn and processed for Fluorescence Activated Cell
Sorting (FACS), as described below.
4.3. Fluorescence Activated Cell Sorting (FACS)
Quantitative cell sorting by ﬂuorimetry was performed using
methods previously described [44].
4.4. PCR detection of HXT6/7 ampliﬁcation
PCR to identify the ampliﬁcation of HXT6/7 was carried out using
primers and PCR conditions as described in [41].
4.5. Whole genome sequencing and mutation determination
Clones from each of the 3 replicate chemostat populations were
paired-end sequenced (2 × 100 bp) using the Illumina HiSeq 2000. Sequencing libraries were constructed for each clone using the Illumina
Genomic DNA sample prep kit from 5 μg of genomic DNA and each libraries were multiplexed on a single ﬂow cell lane. Sequence analysis
was performed as follows, using default parameters unless otherwise noted. Fastq ﬁles were ﬁrst trimmed to remove adaptor sequences using cutadapt [60], and reads were mapped to a modiﬁed
S288c reference genome that we generated previously [41] using
bwa-short in BWA v0.5.9-r16 [61]. PCR duplicates in the resulting
bam ﬁles were marked using Picard MarkDuplicates v1.45, and
then indel realignment and base quality score recalibration were
performed with GATK v1.0.5777 [62,63]. SNPs and indels were then
called with the GATK Uniﬁed Genotyper using default parameters.
SNPs were then hard ﬁltered using ﬁlters “QD b 2.0”, “MQ b 40.0”,
“FS N 60.0”, “HaplotypeScore N 13.0”, “MQRankSum b − 12.5”, and
“ReadPosRankSum b − 8.0”, while indels were hard ﬁltered using
“FS N 200.0”, “QD b 2.0”, and “ReadPosRankSum b −20.0”. A list of all
SNPs and indels was then compiled, and annotated to indicate the
affected gene, and likely outcome of that change.
Acknowledgments
The authors gratefully acknowledge funding from NIH (R01HG003328) to GS and NASA to FR (NNX07AJ28G), which supported
our research and preparation of this manuscript. The manuscript was
signiﬁcantly improved by helpful discussions with Margie Kinnersley,
and Evgueny Kroll, and we thank Julian Adams and Michael Desai for
additional comments. Analysis of ﬂuorescently labeled yeast populations was made possible by the expertise of Pam Shaw, staff scientist
at the University of Montana Fluorescence Cytometry Core Facility,
which has been in part supported by National Institutes of Health
grant P20RR017670.
References
[1] S.J. Gould, R.C. Lewontin, The spandrels of San Marco and the Panglossian paradigm:
a critique of the adaptationist programme, Containing papers of a biological
character. Royal SocietyProc. R. Soc. Lond. Ser. B 205 (1979) 581–598.

K.E. Chiotti et al. / Genomics 104 (2014) 431–437
[2] R. Nielsen, Adaptionism—30 years after Gould and Lewontin, Evolution 63 (2009)
2487–2490.
[3] S. Wright, The roles of mutation, inbreeding, crossbreeding and selection in
evolution, Proceedings of the Sixth Congress on Genetics, Ithaca, New York, 1932,
pp. 355–366.
[4] S. Wright, Surfaces of selective value revisited, Am. Nat. 131 (1988) 115–123.
[5] M.C. Whitlock, P.C. Phillips, F.B.G. Moore, S.J. Tonsor, Multiple ﬁtness peaks and
epistasis, Annu. Rev. Ecol. Syst. 26 (1995) 601–629.
[6] D.M. Weinreich, N.F. Delaney, M.A. Depristo, D.L. Hartl, Darwinian evolution can follow only very few mutational paths to ﬁtter proteins, Science 312 (2006) 111–114.
[7] M.L. Salverda, E. Dellus, F.A. Gorter, A.J. Debets, J. van der Oost, R.F. Hoekstra, D.S.
Tawﬁk, J.A. de Visser, Initial mutations direct alternative pathways of protein
evolution, PLoS Genet. 7 (2011) e1001321.
[8] I.S. Povolotskaya, F.A. Kondrashov, Sequence space and the ongoing expansion of
the protein universe, Nature 465 (2010) 922–926.
[9] D. Heckmann, S. Schulze, A. Denton, U. Gowik, P. Westhoff, A.P. Weber, M.J. Lercher,
Predicting C4 photosynthesis evolution: modular, individually adaptive steps on a
Mount Fuji ﬁtness landscape, Cell 153 (2013) 1579–1588.
[10] E.D. Brodie, Why evolutionary genetics does not always add up, in: J.B. Wolf, E.D.
Brodie, M.J. Wade (Eds.), Epistasis and the Evolutionary Process, Oxford University
Press, New York, 2000.
[11] S. Gavrilets, Fitness Landscapes and the Origin of Species, Princeton University Press,
2004.
[12] P.C. Phillips, Epistasis—the essential role of gene interactions in the structure and
evolution of genetic systems, Nat. Rev. Genet. 9 (2008) 855–867.
[13] F.J. Poelwijk, D.J. Kiviet, D.M. Weinreich, S.J. Tans, Empirical ﬁtness landscapes reveal
accessible evolutionary paths, Nature 445 (2007) 383–386.
[14] M. Lunzer, S.P. Miller, R. Felsheim, A.M. Dean, The biochemical architecture of an
ancient adaptive landscape, Science 310 (2005) 499–501.
[15] G. Zhu, G.B. Golding, A.M. Dean, The selective cause of an ancient adaptation, Science
307 (2005) 1279–1282.
[16] A. Dawid, D.J. Kiviet, M. Kogenaru, M. de Vos, S.J. Tans, Multiple peaks and reciprocal
sign epistasis in an empirically determined genotype–phenotype landscape, Chaos
20 (2010) 026105.
[17] H.H. Chou, H.C. Chiu, N.F. Delaney, D. Segre, C.J. Marx, Diminishing returns epistasis
among beneﬁcial mutations decelerates adaptation, Science 332 (2011) 1190–1192.
[18] D.M. Weinreich, R.A. Watson, L. Chao, Perspective: sign epistasis and genetic
constraint on evolutionary trajectories, Evolution 59 (2005) 1165–1174.
[19] F.J. Poelwijk, S. Tanase-Nicola, D.J. Kiviet, S.J. Tans, Reciprocal sign epistasis is a
necessary condition for multi-peaked ﬁtness landscapes, J. Theor. Biol. 272 (2011)
141–144.
[20] D.B. Weissman, M.M. Desai, D.S. Fisher, M.W. Feldman, The rate at which asexual
populations cross ﬁtness valleys, Theor. Popul. Biol. 75 (2009) 286–300.
[21] E.R. Lozovsky, T. Chookajorn, K.M. Brown, M. Imwong, P.J. Shaw, S.
Kamchonwongpaisan, D.E. Neafsey, D.M. Weinreich, D.L. Hartl, Stepwise
acquisition of pyrimethamine resistance in the malaria parasite, Proc. Natl.
Acad. Sci. U. S. A. 106 (2009) 12025–12030.
[22] A. Wellner, M. Raitses Gurevich, D.S. Tawﬁk, Mechanisms of protein sequence
divergence and incompatibility, PLoS Genet. 9 (2013) e1003665.
[23] M. Lunzer, G.B. Golding, A.M. Dean, Pervasive cryptic epistasis in molecular
evolution, PLoS Genet. 6 (2010) e1001162.
[24] E.A. Ortlund, J.T. Bridgham, M.R. Redinbo, J.W. Thornton, Crystal structure of an ancient protein: evolution by conformational epistasis, Science 317 (2007) 1544–1548.
[25] A.I. Khan, D.M. Dinh, D. Schneider, R.E. Lenski, T.F. Cooper, Negative epistasis
between beneﬁcial mutations in an evolving bacterial population, Science 332
(2011) 1193–1196.
[26] T. Hinkley, J. Martins, C. Chappey, M. Haddad, E. Stawiski, J.M. Whitcomb, C.J.
Petropoulos, S. Bonhoeffer, A systems analysis of mutational effects in HIV-1
protease and reverse transcriptase, Nat. Genet. 43 (2011) 487–489.
[27] S. Trindade, A. Sousa, K.B. Xavier, F. Dionisio, M.G. Ferreira, I. Gordo, Positive epistasis
drives the acquisition of multidrug resistance, PLoS Genet. 5 (2009) e1000578.
[28] J.A. de Visser, S.C. Park, J. Krug, Exploring the effect of sex on empirical ﬁtness
landscapes, Am. Nat. 174 (Suppl. 1) (2009) S15–S30.
[29] F.J. Poelwijk, D.J. Kiviet, S.J. Tans, Evolutionary potential of a duplicated repressor–
operator pair: simulating pathways using mutation data, PLoS Comput. Biol. 2
(2006) e58.
[30] J. da Silva, S.K. Wyatt, Fitness valleys constrain HIV-1's adaptation to its secondary
chemokine coreceptor, J. Evol. Biol. 27 (2014) 604–615.
[31] J. da Silva, M. Coetzer, R. Nedellec, C. Pastore, D.E. Mosier, Fitness epistasis and
constraints on adaptation in a human immunodeﬁciency virus type 1 protein
region, Genetics 185 (2010) 293–303.
[32] J. Lalic, S.F. Elena, Magnitude and sign epistasis among deleterious mutations in a
positive-sense plant RNA virus, Heredity 109 (2012) 71–77.
[33] J. Yun, C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, H. Rajagopalan, K. Schmidt, J.K.
Willson, S. Markowitz, S. Zhou, L.A. Diaz Jr., V.E. Velculescu, C. Lengauer, K.W. Kinzler,
B. Vogelstein, N. Papadopoulos, Glucose deprivation contributes to the development
of KRAS pathway mutations in tumor cells, Science 325 (2009) 1555–1559.
[34] B. Vogelstein, K.W. Kinzler, Cancer genes and the pathways they control, Nat. Med.
10 (2004) 789–799.
[35] A. Stenzinger, V. Endris, N. Pfarr, M. Andrulis, K. Johrens, F. Klauschen, U. Siebolts, T.
Wolf, P.S. Koch, M. Schulz, W. Hartschuh, S. Goerdt, J.K. Lennerz, C. Wickenhauser,
W. Klapper, I. Anagnostopoulos, W. Weichert, Targeted ultra-deep sequencing
reveals recurrent and mutually exclusive mutations of cancer genes in blastic
plasmacytoid dendritic cell neoplasm, Oncotarget 5 (15) (2014) 6404–6413.
[36] Z.S. Bao, H.M. Chen, M.Y. Yang, C.B. Zhang, K. Yu, W.L. Ye, B.Q. Hu, W. Yan, W. Zhang,
J. Akers, V. Ramakrishnan, J. Li, B. Carter, Y.W. Liu, H.M. Hu, Z. Wang, M.Y. Li, K. Yao,

[37]

[38]

[39]

[40]

[41]

[42]

[43]

[44]

[45]

[46]

[47]

[48]

[49]

[50]

[51]

[52]

[53]

[54]
[55]

[56]

[57]

[58]

[59]
[60]
[61]
[62]

[63]

437

X.G. Qiu, C.S. Kang, Y.P. You, X.L. Fan, W.S. Song, R.Q. Li, X.D. Su, C. Chen, T. Jiang,
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript
in secondary glioblastomas, Genome Res. 24 (2014) 1765–1773.
A. Yoshizawa, S. Sumiyoshi, M. Sonobe, M. Kobayashi, T. Uehara, M. Fujimoto, T.
Tsuruyama, H. Date, H. Haga, HER2 status in lung adenocarcinoma: a comparison
of immunohistochemistry, ﬂuorescence in situ hybridization (FISH), dual-ISH, and
gene mutations, Lung Cancer 85 (3) (2014) 373–378.
K.M. Flynn, T.F. Cooper, F.B. Moore, V.S. Cooper, The environment affects epistatic
interactions to alter the topology of an empirical ﬁtness landscape, PLoS Genet. 9
(2013) e1003426.
D. Moradigaravand, R. Kouyos, T. Hinkley, M. Haddad, C.J. Petropoulos, J.
Engelstadter, S. Bonhoeffer, Recombination accelerates adaptation on a large-scale
empirical ﬁtness landscape in HIV-1, PLoS Genet. 10 (2014) e1004439.
M.F. Schenk, I.G. Szendro, M.L. Salverda, J. Krug, J.A. de Visser, Patterns of epistasis
between beneﬁcial mutations in an antibiotic resistance gene, Mol. Biol. Evol. 30
(2013) 1779–1787.
D.J. Kvitek, G. Sherlock, Reciprocal sign epistasis between frequently experimentally
evolved adaptive mutations causes a rugged ﬁtness landscape, PLoS Genet. 7 (2011)
e1002056.
C.J. Brown, K.M. Todd, R.F. Rosenzweig, Multiple duplications of yeast hexose
transport genes in response to selection in a glucose-limited environment, Mol.
Biol. Evol. 15 (1998) 931–942.
D. Gresham, M.M. Desai, C.M. Tucker, H.T. Jenq, D.A. Pai, A. Ward, C.G. DeSevo, D.
Botstein, M.J. Dunham, The repertoire and dynamics of evolutionary adaptations to
controlled nutrient-limited environments in yeast, PLoS Genet. 4 (2008) e1000303.
K.C. Kao, G. Sherlock, Molecular characterization of clonal interference during
adaptive evolution in asexual populations of Saccharomyces cerevisiae, Nat. Genet.
40 (2008) 1499–1504.
C. Verduyn, E. Postma, W.A. Scheffers, J.P. Van Dijken, Effect of benzoic acid on metabolic ﬂuxes in yeasts: a continuous-culture study on the regulation of respiration
and alcoholic fermentation, Yeast 8 (1992) 501–517.
D.J. Kvitek, G. Sherlock, Whole genome, whole population sequencing reveals that
loss of signaling networks is the major adaptive strategy in a constant environment,
PLoS Genet. 9 (2013) e1003972.
G.I. Lang, D.P. Rice, M.J. Hickman, E. Sodergren, G.M. Weinstock, D. Botstein, M.M.
Desai, Pervasive genetic hitchhiking and clonal interference in forty evolving yeast
populations, Nature 500 (2013) 571–574.
S. Kryazhimskiy, D.P. Rice, E.R. Jerison, M.M. Desai, Microbial evolution. Global
epistasis makes adaptation predictable despite sequence-level stochasticity, Science
344 (2014) 1519–1522.
J.W. Wenger, J. Piotrowski, S. Nagarajan, K. Chiotti, G. Sherlock, F. Rosenzweig,
Hunger artists: yeast adapted to carbon limitation show trade-offs under carbon
sufﬁciency, PLoS Genet. 7 (2011) e1002202.
J.I. Roop, R.B. Brem, Rare variants in hypermutable genes underlie common morphology and growth traits in wild Saccharomyces paradoxus, Genetics 195 (2013)
513–525.
B. Oud, V. Guadalupe-Medina, J.F. Nijkamp, D. de Ridder, J.T. Pronk, A.J. van Maris,
J.M. Daran, Genome duplication and mutations in ACE2 cause multicellular, fastsedimenting phenotypes in evolved Saccharomyces cerevisiae, Proc. Natl. Acad. Sci.
U. S. A. 110 (2013) E4223–E4231.
A.L. Paulsel, A.J. Merz, D.P. Nickerson, Vps9 family protein Muk1 is the second Rab5
guanosine nucleotide exchange factor in budding yeast, J. Biol. Chem. 288 (2013)
18162–18171.
M. Cabrera, H. Arlt, N. Epp, J. Lachmann, J. Grifﬁth, A. Perz, F. Reggiori, C. Ungermann,
Functional separation of endosomal fusion factors and the class C core vacuole/
endosome tethering (CORVET) complex in endosome biogenesis, J. Biol. Chem.
288 (2013) 5166–5175.
D. Mayhew, R.D. Mitra, Transcription factor regulation and chromosome dynamics
during pseudohyphal growth, Mol. Biol. Cell 25 (2014) 2669–2676.
D.E. Dykhuizen, A.M. Dean, Experimental evolution from the bottom up, in: T.
Garland Jr., M.R. Rose (Eds.), Experimental Evolution: Concepts, Methods, and Applications of Selection Experiments, University of California Press, 2009, pp. 67–87.
T.L. Ferea, D. Botstein, P.O. Brown, R.F. Rosenzweig, Systematic changes in gene expression patterns following adaptive evolution in yeast, Proc. Natl. Acad. Sci. U. S. A.
96 (1999) 9721–9726.
A. Roy, D. Jouandot 2nd, K.H. Cho, J.H. Kim, Understanding the mechanism of
glucose-induced relief of Rgt1-mediated repression in yeast, FEBS open bio 4
(2014) 105–111.
K.M. Flick, N. Spielewoy, T.I. Kalashnikova, M. Guaderrama, Q. Zhu, H.C. Chang, C.
Wittenberg, Grr1-dependent inactivation of Mth1 mediates glucose-induced
dissociation of Rgt1 from HXT gene promoters, Mol. Biol. Cell 14 (2003) 3230–3241.
F. Winston, C. Dollard, S.L. Ricupero-Hovasse, Construction of a set of convenient
Saccharomyces cerevisiae strains that are isogenic to S288C, Yeast 11 (1995) 53–55.
M. Martin, Cutadapt removes adapter sequences from high-throughput sequencing
reads, EMBnet J. 17 (2011) 10–12.
H. Li, R. Durbin, Fast and accurate short read alignment with Burrows–Wheeler
transform, Bioinformatics 25 (2009) 1754–1760.
M.A. DePristo, E. Banks, R. Poplin, K.V. Garimella, J.R. Maguire, C. Hartl, A.A.
Philippakis, G. del Angel, M.A. Rivas, M. Hanna, A. McKenna, T.J. Fennell, A.M.
Kernytsky, A.Y. Sivachenko, K. Cibulskis, S.B. Gabriel, D. Altshuler, M.J. Daly, A
framework for variation discovery and genotyping using next-generation DNA
sequencing data, Nat. Genet. 43 (2011) 491–498.
A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K.
Garimella, D. Altshuler, S. Gabriel, M. Daly, M.A. DePristo, The genome analysis
toolkit: a MapReduce framework for analyzing next-generation DNA sequencing
data, Genome Res. 20 (2010) 1297–1303.

